EUVIMEDEUVIMED entdecken
Crossref

Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation

Iman A Y Ghannam, Ahmed M El Kerdawy, Marwa M Mounier, Mahmoud T Abo-Elfadl, Islam H Ali

Archiv der Pharmazie · 2023-02 · 356 (2)

DOI: 10.1002/ardp.202200341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 18.11.2022. Verfasst von Iman A Y Ghannam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Egypt. Hauptthemen laut MEDLINE: Urea, Antineoplastic Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Science and Technology Development Fund (STDF), Egypt, Science and Technology Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Two series of diaryl urea derivatives, 6a–k and 7a–n , were synthesized. All the newly synthesized compounds were tested against the NCI (US) cancer cell lines via SRB assay. The p ‐chloro‐ m ‐trifluoromethyl phenyl derivatives 6e–g and 7e–g showed the most potent cytotoxic activity with a GI 50 value range of 1.2–15.9 µM. Furthermore, the p ‐fluorobenzyloxy diaryl urea derivative 7g revealed the most potent cytotoxicity against eight cancer cell lines in the MTT assay with IC 50 values below 5 µM. Compounds 6a–k and 7a–n were tested for their vascular endothelial growth factor receptor‐2 (VEGFR‐2) kinase inhibitory activities. The p ‐chloro‐ m ‐trifluoromethyl diaryl urea benzyloxy derivatives 7e–i and the p ‐methoxydiaryl urea benzyloxy derivatives 7k, 7l , and 7n were found to be the most active compounds as VEGFR‐2 inhibitors in the benzyloxy series 7 , with an IC 50 range of 0.09–4.15 µM. In the 2‐oxo‐2‐phenylethoxy series 6 , compounds 6e–g and 6i were reported with IC 50 values of 0.94, 0.54, 2.71, and 4.81 µM, respectively. Moreover, compounds 7e and 7g induced apoptosis, causing cell cycle arrest in the G2/M phase. In addition, 7g showed an antimigratory effect in A‐375 cells and inhibited the VEGFR‐2 expression in an immunohistofluorescence study. Molecular docking simulations on VEGFR‐2 as well as ADME properties prediction were also performed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UreaAntineoplastic AgentsHumansMolecular StructureStructure-Activity RelationshipMolecular Docking SimulationVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor ACell ProliferationProtein Kinase InhibitorsDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

VEGFR-2 inhibitorsanticancer evaluationdiaryl urea derivativesmolecular modeling

Substanzen

UreaVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor AAntineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Pharmaceutical Chemistry, School of Pharmacy, Newgiza University (NGU), Newgiza, Egypt.
  • Department of Pharmacognosy, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Egypt.
  • Cancer Biology and Genetics Laboratory, Centre of Excellence for Advanced Sciences, National Research Centre, Dokki, Egypt.
  • Biochemistry Department, Biotechnology Research Institute, National Research Centre, Dokki, Egypt.

Förderung

  • Science and Technology Development Fund (STDF), Egypt
  • Science and Technology Development Fund

Zitieren

APA

Ghannam, I. A. Y., El Kerdawy, A. M., Mounier, M. M., Abo-Elfadl, M. T., & Ali, I. H. (2023). Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation. Archiv der Pharmazie, 356(2). https://doi.org/10.1002/ardp.202200341

Vancouver

Ghannam IAY, El Kerdawy AM, Mounier MM, Abo-Elfadl MT, Ali IH. Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation. Archiv der Pharmazie. 2023;356(2). doi:10.1002/ardp.202200341

BibTeX
@article{Ghannam2023,
  author = {Ghannam, Iman A Y and El Kerdawy, Ahmed M and Mounier, Marwa M and Abo-Elfadl, Mahmoud T and Ali, Islam H},
  title = {Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation},
  journal = {Archiv der Pharmazie},
  year = {2023},
  volume = {356},
  number = {2},
  doi = {10.1002/ardp.202200341}
}
Kostenlos starten →